Weaver Gaines to Present at 2021 BioFlorida Conference

Gainesville, FL – December 6, 2021 – Evren Co-founder and Executive Chairman Weaver Gaines will be presenting at the annual BioFlorida Conference in Orlando. Gaines will compete alongside 14 other top executives and entrepreneurs from emerging life sciences companies in the BioPitch semi-finals.


Selected companies will deliver pitches to life science investors in closed sessions. Four finalists will be given the opportunity to pitch to the entire conference at the General Session on December 10. The winning company will be awarded $10,000.


Gaines is a founding director of BioFlorida and will be presenting his namesake award at the conference in addition to participating in the BioPitch competition.


“We are always excited for the opportunity to share Evren’s progress with local industry leaders,” Gaines said. “Florida’s life science industry has shown impressive growth since the formation of BioFlorida and I’m thrilled to contribute to that progress in some way.”



The 2021 BioFlorida Conference will be hosted at the Renaissance Orlando at SeaWorld, from December 8-10. Online registration is available on BioFlorida’s website (link).


About Evren Technologies, Inc.

Evren Technologies, founded in 2018, is a privately-held medical device company headquartered in Newberry, Florida, near the University of Florida. Evren’s mission is to advance the treatment of PTSD and other psychological disorders through wearable neuromodulation products. The Company’s initial product, the Phoenix™, provides transcutaneous vagal nerve stimulation (tVNS) to treat PTSD in an effective, discreet earbud design.


About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 94,000 Floridians.


CONTACT:

M. Blythe Karow

Evren Technologies, Inc.

Co-founder & CEO

352.533.3381 x702

blythe.karow@evrenvns.com

36 views0 comments